Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer
Bidyadhar Sethy
Richa Upadhyay
Iin Narwanti
Zih-Yao Yu
Sung-Bau Lee
Jing-Ping Liou
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1007/s10495-024-02023-7
Oct 12, 2024
Version published to 10.21203/rs.3.rs-4661784/v1 on Research Square
Jul 24, 2024
Related articles
Efficacy of a New Selective Indole-based Histone Deacetylase 10 Inhibitor in Targeted Anticancer Therapy
This article has 9 authors:
Amer H. Tarawneh
Salah A. Al-Trawneh
Talha Z. Yesiloglu
Matthes Zessin
Dina Robaa
Cyril Barinka
Mike Schutkowski
Wolfgang Sippl
Samir A. Ross
Role of the NuRD complex and altered proteostasis in cancer cell quiescence
This article has 14 authors:
Qi Jiang
Michelle Ertel
Austin Arrigo
Sara Sannino
Jennifer L. Goeckeler-Fried
April Sagan
Betsy Ann Varghese
Daniel D. Brown
Wayne Stallaert
Adrian Lee
Amanda M. Clark
Jeffrey L. Brodsky
Hatice U. Osmanbeyoglu
Ronald J. Buckanovich
HDAC3 inhibition as a therapeutic strategy in T-cell acute lymphoblastic leukemia via the TYK2-STAT1-BCL2 signaling pathway
This article has 12 authors:
Zhenyang Gu
Yuchen Liu
Yifan Jiao
Hao Wang
Lili Wang
Ning Le
Xiawei Zhang
Qingyang Liu
Yang Xu
Chunji Gao
Daihong Liu
Liping Dou
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up